Prognostic Significance of CD163+ and/or CD206+ Tumor-Associated Macrophages Is Linked to Their Spatial Distribution and Tumor-Infiltrating Lymphocytes in Breast Cancer
Cancers · 05.06.2024 · 16 (11) · 2147
DOI: 10.3390/cancers16112147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 05.06.2024. Verfasst von Canbin Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Translational Oncology, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of …. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Medical Research Fund, Hong Kong, CUHK direct grant, Health and Medical Research Fund.
Abstract (Originalsprache)
Tumor-associated macrophages (TAMs) is a key element in the breast tumor microenvironment. CD163 and CD206 have been utilized for TAM identification, but the clinical implications of TAMs identified by these markers have not been thoroughly explored. This study conducted a comparative analysis of CD163 and CD206 TAMs using digital image analysis, focusing on their spatial distribution and prognostic significance in relation to tumor-infiltrating lymphocytes (TILs). Distinct clinico-pathological and prognostic characteristics were noted between the two types of TAMs. CD163 TAMs were linked to high-grade tumors (p = 0.006), whereas CD206 TAMs were associated with a higher incidence of nodal metastasis (p = 0.033). CD206 TAMs were predominantly found in the stroma, with more cases being stromal CD206-high (sCD206-high) than tumoral CD206-high (tCD206-high) (p = 0.024). Regarding prognostication, patients stratified according to stromal and tumoral densities of CD163 showed different disease-free survival (DFS) time. Specifically, those that were sCD163-low but tCD163-high exhibited the poorest DFS (chi-square = 10.853, p = 0.013). Furthermore, a high sCD163-to-stromal-TILs ratio was identified as an independent predictor of unfavorable survival outcomes (DFS: HR = 3.477, p = 0.018). The spatial distribution and interactions with TILs enhanced the prognostic value of CD163 TAMs, while CD206 TAMs appeared to have limited prognostic utility in breast cancer cases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Translational Oncology, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Department of Pathology, The University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Joshua Li
Förderung
- Health and Medical Research Fund, Hong Kong
- CUHK direct grant
- Health and Medical Research Fund
- Cheng Yue Pui Charity Foundation
Zitieren
APA
Fang, C., Cheung, M. Y., Chan, R. C., Poon, I. K., Lee, C., To, C. C., Tsang, J. Y., Li, J., & Tse, G. M. (2024). Prognostic Significance of CD163+ and/or CD206+ Tumor-Associated Macrophages Is Linked to Their Spatial Distribution and Tumor-Infiltrating Lymphocytes in Breast Cancer. Cancers, 16(11), 2147. https://doi.org/10.3390/cancers16112147
Vancouver
Fang C, Cheung MY, Chan RC, Poon IK, Lee C, To CC, et al. Prognostic Significance of CD163+ and/or CD206+ Tumor-Associated Macrophages Is Linked to Their Spatial Distribution and Tumor-Infiltrating Lymphocytes in Breast Cancer. Cancers. 2024;16(11):2147. doi:10.3390/cancers16112147
BibTeX
@article{Fang2024,
author = {Fang, Canbin and Cheung, Maisy Y and Chan, Ronald C and Poon, Ivan K and Lee, Conrad and To, Curtis C and Tsang, Julia Y and Li, Joshua and Tse, Gary M},
title = {Prognostic Significance of CD163+ and/or CD206+ Tumor-Associated Macrophages Is Linked to Their Spatial Distribution and Tumor-Infiltrating Lymphocytes in Breast Cancer},
journal = {Cancers},
year = {2024},
volume = {16},
number = {11},
pages = {2147},
doi = {10.3390/cancers16112147}
}
EUVIMED